Industry: Healthcare
Published Date: February-2023
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 250
Report ID: PMRREP33349
The Global Pain Relief Patches Market is valued at US$ 1.2 billion in 2024 and is estimated to reach US$ 1.9 billion by 2032, expanding at a CAGR of 4.9%. According to this new study by Persistence Market Research, non-steroidal anti-inflammatory drug patches account for a leading market share of 39.5%.
A combination of pharmaceutical sciences and nanotechnology has been a meaningful step toward creating more effective chronic pain medications with fewer side effects. The incorporation of nanotechnology has boosted the sales of pain relief patches, resulting in the authorization of several nanomaterials for medicinal use.
| Report Attributes | Details |
|---|---|
| Pain Relief Patches Market Size (2023) | US$ 1.1 Billion |
| Estimated Market Value (2024) | US$ 1.2 Billion |
| Forecasted Market Value (2032) | US$ 1.9 Billion |
| Global Market Growth Rate (2024 to 2032) | 4.9% CAGR |
| Market Share of Top 5 Countries | 54.2% |
One of the major factors for the growing demand for pain relief patches is the increasing prevalence of osteoarthritis, diabetic neuropathy, joint injuries, obesity, and disorders caused by hereditary factors. The increasing incidence of metabolic disorders is driving demand for non-opioid pain management treatment patches.
Owing to the rising prevalence of osteoarthritis and growing demand for transdermal patches for treating bone disorders, the market is expected to increase steadily over the coming years.
The increasing prevalence of cancer is expected to drive the demand for pain relief patches. Chronic pain is a common side effect of cancer treatments and, if left untreated, can significantly impact survivors’ quality of life. To prevent premature such comorbid conditions and side effects such as psychological issues and fatigue, lifestyle changes are recommended. Insufficient stress response can cause dysregulation in the autonomic, endocrine, and inflammatory processes of the body.
Over the coming years, transdermal patches are expected to be an effective treatment option for chronic pain. This presents an opportunity for pain relief patch manufacturers to develop and launch technologically advanced devices to enhance treatment efficacy.
National initiatives have recently been released to promote effective and safe pain management options. Topical formulations offer significant advantages over other delivery methods, as they avoid gastrointestinal absorption and deliver effective concentrations directly to targeted tissues.
Lack of awareness among the general population poses a hindrance to the widespread adoption of pain relief patches.
While pain relief patches and transdermal patches offer an effective method of delivering medication through the skin, some individuals may develop an allergic reaction to the adhesive glue used in these products. This can lead to contact dermatitis, a skin condition that causes blisters, rash, and flaking.
Latex, which is commonly used in the production of pain relief patches, can trigger an allergic reaction in some people. This limits the options available to them and consequently restricts the sales of pain relief patches.
Why is the United States a Lucrative Market for Manufacturers of Pain Relief Patches?
Increasing prevalence of car accidents, traumatic injuries, and chronic illnesses such as heart attacks and blood clotting is boosting demand for pain relief patches in the United States.
How is Demand for Pain Relief Patches Evolving in the United Kingdom?
The increasing use of opioids for treating pain related to trauma, injury, and severe and chronic illnesses, as well as post-surgical pain is driving the demand for pain relief patches in this country.
Which Factors are Driving the Demand for Pain Relief Patches in China?
Which Type of Pain Relief Patch is in High Demand Worldwide?
For Which Medical Indication is Pain Relief Patches Generating Significant Sales?
Changes in lifestyle and dietary choices and environmental factors have had a significant impact on the female body. Dysmenorrhea, or painful periods, is a major cause of pelvic discomfort among women.
Due to the presence of many local and major players, the global market for pain relief patches is highly fragmented. In response to competition from local players, major market players are strengthening their distribution channels to expand their reach to a larger customer base. Additionally, manufacturers are developing pain relief patches with improved material compositions to enhance ease of use.
| Attribute | Details |
|---|---|
| Forecast Period | 2024 to 2032 |
| Historical Data Available for | 2017 to 2023 |
| Market Analysis | US$ Billion for Value |
| Key Regions Covered |
|
| Key Countries Covered |
|
| Key Market Segments Covered |
|
| Key Companies Profiled |
|
| Pricing | Available upon Request |
By Product Type:
By Indication:
By Distribution Channel:
By Region:
To know more about delivery timeline for this report Contact Sales
The global pain relief patches market is valued at US$ 1.1 billion in 2021 and is set to expand 1.6X by 2032.
Sales of pain relief patches are expected to reach USS$ 1.9 billion by 2032.
Rising prevalence of osteoarthritis and nerve pain is boosting the demand for pain relief patches.
The U.S., the U.K., Germany, China, and Japan are generating high demand for pain relief patches.
North America is one of the key markets for pain relief patches, with the U.S. accounting for 91.5% share of the North American market.
Sales of pain relief patches in Europe are expected to increase at a CAGR of 4.4% through 2032.
The United States, the United Kingdom, Germany, Japan, and China are leading producers of pain relief patches.
Viatris, Teva Pharmaceutical Industries, and Sanofi are key producers of pain relief patches.
Demand for pain relief patches in Latin America is expected to increase at a CAGR of 3.6% through 2032.
